治疗用雷射的全球市场预测(2022年～2027年)

全球治疗用雷射的市场规模在2020年估算为1,036亿6,400万美金。

本报告提供全球治疗用雷射市场相关调查，提供市场规模和预测，COVID-19影响，市场促进因素及课题，市场趋势，各市场区隔的市场分析，竞争情形，主要企业的简介等系统性资讯。

目录

第1章 简介

• 市场概要
• COVID-19影响
• 市场定义
• 市场区隔

第2章 调查手法

• 调查资料
• 前提条件

第3章 摘要整理

• 调查的重点

第4章 市场动态

• 推动市场要素
• 阻碍市场要素
• 波特的五力分析
  • 供给企业谈判力
  • 买方议价能力
  • 新加入厂商者的威胁
  • 替代品的威胁
  • 竞争企业间的敌对关係
• 产业的价值链分析

第5章 全球治疗用雷射市场:不同治疗

• 简介
• 二氧化碳雷射
• YAG(钇铝石榴石)雷射
• 脉衝染料雷射
• 氩雷射
• 低层级雷射治疗(LLLT)

第6章 全球治疗用雷射市场:各用途

• 简介
• LASIK·雷射眼科手术
• 牙齿美白
• 消除美容疤痕、纹身或皱纹
• 肿瘤切除
• 其他

第7章 全球治疗用雷射市场:各地区

• 简介
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 南美
  • 巴西
  • 阿根廷
  • 其他
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他
• 中东·非洲
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他
• 亚太地区
  • 中国
  • 日本
  • 韩国
  • 印度
  • 泰国
  • 其他

第8章 竞争环境与分析

• 主要企业策略分析
• 新兴企业与市场的有利性
• 合併，收购，契约，合作
• 供应商的竞争矩阵

第9章 企业简介

• BTL
• ERCHONIA CORPORATION
• Theralase (R) Technologies Inc.
• Cutting Edge Laser Technologies
• BioFlex Laser Therapy
• El.En. Group
• Lynton Lasers Ltd.
• Fotona d.o.o.
• Capillus, LLC
• LiteCure, LLC

The global therapeutic laser market was valued at US$103.664 billion in 2020.

A therapeutic laser system is a drug-free, non-invasive therapy approach that relieves chronic and acute pain while also improving blood circulation. These devices employ LASER laser pulses that penetrate through the skin without creating warmth, injury, or other negative effects. The therapeutic laser system speeds up wound healing and lowers soft tissue inflammation and discomfort. Therapeutic laser therapy is viewed as an alternative, if not a supplement, to standard medication and surgical treatment. Therapeutic laser systems include a long-term therapeutic effect by addressing the fundamental causes of illness disorders.

Increased cancer incidences

The need for a therapeutic laser is increasing due to rising cancer occurrences globally, an increase in the number of operations, and increased awareness of self-care and self-management. Furthermore, increased disposable income, rising healthcare spending, and shorter hospital stays would drive the worldwide therapeutic laser market in the projected decade and beyond. Furthermore, increased disposable income, rising healthcare spending, and shorter hospital stays would drive the worldwide therapeutic laser market in the projected decade and beyond. Moreover, several companies have taken the initiative to launch new innovative products that have propelled the market to grow during the projected period. For instance, Theralase Technology, a Canadian producer of patent laser technologies in both the Anti-Cancer Therapy (ACT) and Medical Laser Technology (MLT) sectors, intends to introduce new, breakthrough pain and cancer solutions in 2021. They've also shown that their primary PDC can eliminate several viruses, including H1N1 flu and Zika.

North America has been a major market for therapeutic lasers until now and is expected to witness a surge in its global market share.

This can be attributed to the growing prevalence of demand for cosmetic surgeries across several countries in this region. Primary cosmetic treatments for veins, skin resurfacing, and hair removal using laser therapy have increased significantly in the region. For instance, according to the American Society of Plastic Surgeons annual report, it was reported that 168,682 laser treatments for veins, 997,245 laser skin resurfacing, and 757,808 laser removal procedures were performed in 2020. Thus, these extensive medical applications and the wide adoption of these procedures have propelled the demand for the therapeutic lasers market in the region. Further, the growing demand for these lasers can also be attributed to an increase in the provision of patents in the region. For instance, in July 2021, Aspen Laser LLC, which is a major medical solutions company, was awarded a new patent by the USPTO (U.S. Patent and Trademark Office). The patent was reported to cover particular laser devices that would be manufactured by the company and sold in the veterinary and medical markets.

Furthermore, major companies in the region have been focused on the implementation of strategic initiatives such as mergers, collaborative agreements, and acquisitions, for the consolidation of their position in the market. For instance, in September 2021, Boston Scientific completed the acquisition of the worldwide surgical business of Lumenis LTD, an energy-based medical solutions company, from an affiliate of BPEA (Baring Private Equity Asia). The surgical business of Lumenis comprised of fibers, premier laser systems, and accessories that are deployed in the otolaryngology and urology procedures. Thus, developments like these are further expected to propel growth in the market.

Market Key Developments

• In July 2022, The Palm Beach County Golf Association established an official partnership with LUMACARE DUO, a premier supplier of cold laser treatment for acute and chronic pain. To fulfill their clients' growing demands, they created a new type of Cold Laser system, one that is meant to enhance treatment efficacy and improve patient results.
• In October 2020, Summus Medical Laser, the leading manufacturer of high-powered laser treatment devices, announces the release of the Horizon Medical Laser System, the first Class IV therapy laser system particularly developed for the medical profession. The Horizon Medical Laser System is the inaugural Class IV diode laser created specifically for the medical sector. The system brings a unique capacity combining four separate frequencies that can be regulated individually, offering the most sophisticated laser treatment option on the market, with 28 watts of power. With condition-specific protocols, its dynamic mix of power, wavelength, and pulse offers an appropriate therapeutic laser dosage in less time.
• In July 2019, NIDEK CO., LTD., a global pioneer in the design, production, and distribution of ophthalmic, eye care, and lens edging equipment, announced the release of LPM optional technology, a low wattage mode for the YLC-500 Vixi laser photocoagulator. By lowering the laser strength during photocoagulation, LPM provides a therapeutic impact on the retina. The typical laser strength is reduced by a predetermined ratio during therapy, resulting in less invasive photocoagulation of the macular area.

Segmentation

• By Therapy

Carbon Dioxide Laser

YAG (yttrium aluminum garnet) Laser

Pulsed Dye Laser

Argon Laser

Low level laser therapy (LLLT)

• By Application

LASIK or Laser Eye Surgery

Teeth Whitening

Cosmetic Scar, Tattoo or Wrinkle Removal

Tumor Removal

Others

• By Geography

North America

• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others

Europe

• Germany
• France
• United Kingdom
• Spain
• Others

Middle East and Africa

• Saudi Arabia
• UAE
• Others

Asia Pacific

• China
• Japan
• South Korea
• India
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. COVID-19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. GLOBAL THERAPEUTIC LASER MARKET, BY THERAPY

• 5.1. Introduction
• 5.2. Carbon Dioxide Laser
• 5.3. YAG (yttrium aluminum garnet) Laser
• 5.4. Pulsed Dye Laser
• 5.5. Argon Laser
• 5.6. Low level laser therapy (LLLT)

6. GLOBAL THERAPEUTIC LASER MARKET, BY APPLICATION

• 6.1. Introduction
• 6.2. LASIK or Laser Eye Surgery
• 6.3. Teeth Whitening
• 6.4. Cosmetic Scar, Tattoo or Wrinkle Removal
• 6.5. Tumor Removal
• 6.6. Others

7. GLOBAL THERAPEUTIC LASER MARKET, BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. Japan
  • 7.6.3. South Korea
  • 7.6.4. India
  • 7.6.5. Thailand
  • 7.6.6. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrativeness
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

• 9.1. BTL
• 9.2. ERCHONIA CORPORATION
• 9.3. Theralase® Technologies Inc.
• 9.4. Cutting Edge Laser Technologies
• 9.5. BioFlex Laser Therapy
• 9.6. El.En. Group
• 9.7. Lynton Lasers Ltd.
• 9.8. Fotona d.o.o.
• 9.9. Capillus, LLC
• 9.10. LiteCure, LLC